Cocrystal Pharma, Inc. (COCP) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts COCP Hot Sheet
Join SI Premium – FREE
Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
- Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
